Literature DB >> 19821527

The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions.

Minggang Zhang1, Yanmei Han, Chaofeng Han, Sheng Xu, Yan Bao, Zhubo Chen, Yan Gu, Dajing Xia, Xuetao Cao.   

Abstract

UNLABELLED: The beta2 integrins play a key role in inflammation and immune responses. The beta2 integrin CD11b has been shown recently to be important in the maintenance of tolerance; however, the underlying mechanisms remain to be fully understood. Natural killer (NK) cells are an important effector of innate immunity but are also a regulator of adaptive immune response. How the activating and inhibitory signals are balanced to determine NK cell function needs to be further identified. CD11b expression was dramatically up-regulated on NK cells once they matured and became activated; therefore, we investigated the role of inducible CD11b in the regulation of NK cells. Neutralizing anti-CD11b antibody enhanced cytotoxicity, interferon-gamma (IFN-gamma) and granzyme B production of Toll-like receptor 3 (TLR3)-triggered NK cells. CD11b-deficient NK cells stimulated with or without the TLR3 ligand polyinosinic:polycytidylic acid [poly(I:C)] exhibited more potent cytotoxicity, and higher production of IFN-gamma and granzyme B. Through in vivo depletion of NK cells and adoptive transfer of CD11b-deficient NK cells, we demonstrated that CD11b-mediated suppression of NK cell function was responsible for attenuation of poly(I:C)-induced acute hepatitis by CD11b.
CONCLUSION: Our findings demonstrate that CD11b negatively regulates NK cell activation and thus attenuates poly(I:C)-induced acute hepatitis. Our study provides a new mechanistic explanation for maintenance of tolerance and control of inflammation by CD11b.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821527     DOI: 10.1002/hep.23168

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

2.  Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation.

Authors:  Juan Liu; Shuxun Liu; Meng Xia; Sheng Xu; Chunmei Wang; Yan Bao; Minghong Jiang; Yue Wu; Tian Xu; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

3.  Tyrosine kinase Btk is required for NK cell activation.

Authors:  Yan Bao; Jian Zheng; Chaofeng Han; Jing Jin; Huanxing Han; Yinping Liu; Yu-Lung Lau; Wenwei Tu; Xuetao Cao
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

4.  Toll-like receptor 3 in liver diseases.

Authors:  Shi Yin; Bin Gao
Journal:  Gastroenterol Res Pract       Date:  2010-09-23       Impact factor: 2.260

5.  MicroRNA transcriptomes of distinct human NK cell populations identify miR-362-5p as an essential regulator of NK cell function.

Authors:  Fang Ni; Chuang Guo; Rui Sun; Binqing Fu; Yue Yang; Lele Wu; Sitong Ren; Zhigang Tian; Haiming Wei
Journal:  Sci Rep       Date:  2015-04-24       Impact factor: 4.379

6.  Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy.

Authors:  Thomas D Barbour; Guang Sheng Ling; Marieta M Ruseva; Liliane Fossati-Jimack; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  Kidney Int       Date:  2016-02-03       Impact factor: 10.612

7.  NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis.

Authors:  Wei Lin; Xuejing Man; Peng Li; Nannan Song; Yingying Yue; Bingqing Li; Yuanbin Li; Yufei Sun; Qiang Fu
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

8.  Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells.

Authors:  Xing-Feng Zheng; Xiao-Yan Hu; Bing Ma; He Fang; Fang Zhang; Yan-Fei Mao; Feng-Yong Yang; Shi-Chu Xiao; Zhao-Fan Xia
Journal:  Front Pharmacol       Date:  2018-08-24       Impact factor: 5.810

9.  Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function.

Authors:  Cheng-Fei Liu; Xiao-Yun Min; Naiyin Wang; Jia-Xing Wang; Ning Ma; Xia Dong; Bing Zhang; Weiju Wu; Zong-Fang Li; Wuding Zhou; Ke Li
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 10.  β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.

Authors:  Monika Bednarczyk; Henner Stege; Stephan Grabbe; Matthias Bros
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.